News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wooldridge James
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| Wooldridge James (Chief Medical Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 54,600 options to buy
@ $13.5, valued at
$737.1k
|
|
| 01/31/2022 |
4
| Wooldridge James (Chief Medical Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 101,180 options to buy
@ $2.05, valued at
$207.4k
|
|
| 08/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/01/2019 |
4
| Wooldridge James (Chief Medical Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 50,200 options to buy
@ $8.36, valued at
$419.7k
|
|
| 02/22/2018 |
4
| Wooldridge James (Chief Medical Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 45,000 options to buy
@ $6.31, valued at
$284k
|
|
| 08/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|